Category: MENA

RIO DE JANEIRO, June 25, 2024 (GLOBE NEWSWIRE) — The inaugural three-day Latin America FII PRIORITY Summit, powered by FII Institute, commenced on Tuesday at the Copacabana Palace Hotel in Rio de Janeiro. Convening global officials, along with business leaders from various sectors, the event will tackle pressing issues under the theme “Invest in Dignity.” The Summit welcomed over 1,500 delegates, who attended 66 sessions featuring more than 190 speakers.

The opening ceremony included remarks by the CEO of FII Institute, Richard Attias; His Excellency Yasir Al-Rumayyan, Governor of the Public Investment Fund, Chairman of Saudi ARAMCO, and Chairman of the Board of FII Institute; and the President of the Republic of Brazil, His Excellency Luiz Inácio Lula da Silva.

In his opening remarks, Attias said, “Today, we gather with a shared mission: to invest in dignity. Dignity is not just a concept; it is a fundamental human right that should be accessible to every individual, regardless of their background, economic status, or social standing.” He added, “In this room, we have the collective power to drive meaningful change. Our collaboration, innovation, and determination can transform lives and communities.”

A fireside chat with Al-Rumayyan highlighted the rising role of Brazil in global investment and economic growth. “There are 12,000 new start-ups, and 12 or 16 unicorns were created here. The potential in Brazil is really big,” he said. When asked about why FII Institute brought the summit to Rio, His Excellency said, “Why did we host the FII in Rio? The question is: Why not? This is one of the greatest cities not only in Brazil, but the world. At the same time, we will have the G20 and COP30.”

For his part, President Lula said, “We all want to make the world capable of welcoming all its inhabitants with dignity—and not just a privileged minority.” The President also highlighted Brazil’s evolving economic and investment landscapes, saying, “The choice to host FII in Rio shows that this is a sign of trust in our country from over 1,000 participants. I’m here to show that Brazil is worthy of this trust.”

The Summit’s flagship Board of Changemakers session featured several notable speakers, including H.R.H. Ambassador Reema Bandar Al-Saud, the Saudi Ambassador to the United States; Magda Chambriard of Petrobras; Marcelo Claure of Claure Group and SHEIN; Bernard Mensah of Bank of America and MLI; Secretary Mike Pompeo, 70th Secretary of State of the United States and Executive Chairman of Impact Investments; and Sir Martin Sorrell of S4 Capital Group.

During the session, Princess Reema stressed the importance of dignity as a collective responsibility, further underscoring the theme of the summit. She said, “We all have a responsibility for the way we speak, think, and engage with people. Dignity is an individual concept, but it is a collective responsibility.” For her part, Ms. Chambriard noted Brazil’s role in the broader global context in maintaining citizen dignity, saying, “The idea is to exercise the power of using all the Brazilian resources and investing based on the respect of the Brazilian society.”

Visionary Brazilian entrepreneur and media personality Luciano Huck and Cecilia Attias, who is Senior VP of Public Affairs and Board Member, RA&A, and Founder and President of the Cecilia Attias Foundation for Women, covered the intersection of media, politics, and responsibility towards both. During the Titan of Industry session, Huck stressed that “The privilege of speaking to 35 million people on global TV is the freedom of speech. I do not treat it as power, but a tremendous responsibility.”

Executives from Goldman Sachs, Franklin Templeton, Morgan Stanley, and Patria Investments set the tone for the rest of the day in a session tackling global market volatility and disruptions and the impact on investors. Exploring a range of approaches, from backing national champions to diversifying across asset classes, the discussion centred on ways to build resilient portfolios, with key insights shared by prominent industry leaders.

Among the notable announcements of the first day of FII PRIORITY Rio de Janeiro, Richard Attias, CEO of FII Institute, announced the Institute’s latest flagship initiative, FII Institute TV. Set to launch fully in the coming months, FII Institute TV is a 24/7 platform offering enhanced content curation, in-depth interviews with global leaders, and expert analysis.

Furthermore, FII Institute’s strategic partner, THIQAH, made a significant announcement for BRICS+ countries, launching their “Certificate of Origin” platform in Brazil in collaboration with CICIBAS. The platform enables exporters and manufacturers to issue and track the status of certificates of origin for manufactured products through a single electronic platform, contributing to a transformation in the commercial and industrial sectors.

E-mail: [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/13c76081-cfa1-42b5-af6f-3edc96d21d1b

GlobeNewswire Distribution ID 1000968141

London, June 24, 2024 (GLOBE NEWSWIRE) — June 24, 2024, London, UK – OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine learning (ML) solutions provider that will work exclusively with OPEN Health. This alliance will see fusion’s market-leading AI capabilities deployed across OPEN Health’s extensive global client base, which includes 49 of the top 50 pharmaceutical companies.

Mary McGregor, Founder of fusion, commented, “OPEN Health provides an unrivalled platform to expand the AI agenda globally in our sector. Our longstanding relationship with OPEN Health leadership facilitated early conversations, enabling us to quickly market-test joint solutions, which led to a swift and unanimous decision to formalize this collaboration. This partnership empowers us to redefine the boundaries of what AI can accomplish in healthcare.”

Margot Hannah,  Chief Executive Officer of Scientific Communications at OPEN Health, expressed her enthusiasm for the partnership: “We immediately recognized the need to expand our capabilities and started a dialog with fusion about an exclusive partnership to provide pioneering solutions that integrate OPEN Health’s capabilities with fusion’s cutting-edge expertise in AI and ML. Fusion’s expertise in this area is unparalleled, and we are excited about the possibilities this partnership brings for our clients.”

Steve Duryee, Chief Operating and Transformation Officer at OPEN Health, added, “We are committed to harnessing the power of cutting-edge technologies, including AI, ML, robotic process automation, and data analytics, to drive higher value and improved outcomes for our clients. With the recent launch of our Solutions Innovation Center, and the addition of fusion to our extended team of elite-level technology partners, we are now in the pole position to deliver the most innovative, technologically advanced solutions to our biopharmaceutical partners.”

By integrating with fusion’s advanced technology, OPEN Health underscores its commitment to leading the AI agenda with socially beneficial innovations to drive innovation and efficiency for clients. Contact OPEN Health to set up an interactive demonstration at www.openhealthgroup.com/contact-us.

About OPEN Health
OPEN Health unites world-class scientific, strategic, and creative expertise to solve complex challenges for global biopharma. We are a flexible, global organization, creating high-performing strategic partnerships with our clients. We embrace our different perspectives and strengths to deliver innovative solutions that have a positive impact on commercial and patient outcomes. OPEN Health unlocks possibilities across consulting, HEOR and market access, scientific communications, and patient engagement. To learn more, visit www.openhealthgroup.com.

About fusion
fusion specializes in delivering AI and ML solutions. Known for its advanced technology and innovative approach, fusion aims to transform the pharmaceutical industry by integrating AI-first solutions. To learn more, visit www.fusionagency.solutions.

Attachment

• OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

Candice Subero
OPEN Health
[email protected]

GlobeNewswire Distribution ID 9157597

Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member states of the Gulf Cooperation Council (GCC) and South Africa. EXBLIFEP® has been approved by the U.S. Food and Drug Administration (FDA) and the European Commission (EC) for the treatment of severe infections earlier in 2024.

Saint-Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) — Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive licensing agreement under which Acino gains the rights to commercialise Allecra’s antibiotic drug EXBLIFEP^® (cefepime/enmetazobactam) within the Republic of South Africa and the member states of the GCC alliance, which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates, effective from 12 June 2024. In addition, the companies have signed a supply agreement under which Allecra will supply the cefepime/enmetazobactam finished product in the above territories.

“Acino has established itself as a leader in South Africa and the GCC region. They are an ideal partner to support us as we build towards commercialisation of EXBLIFEP^® following our regulatory approvals in the US and EU,” stated Andreas Kranzusch, Chief Financial Officer and Managing Director at Allecra Therapeutics. “This agreement reflects the understanding that there remains a significant global need to address the dangerous increase of resistance to standard-of-care antibiotics, and we look forward to working with Acino to address this.”

“At Acino, we are dedicated to providing novel healthcare solutions to physicians and patients, aiming to alleviate the health burden in emerging markets. We are incredibly excited to partner with Allecra to offer access to this innovative product in two key geographic regions and, potentially, beyond,” said Andrew Bird, CEO (ai) at Acino. “We are committed to expediting the registration process in these designated markets to ensure hospitals’ swift access to EXBLIFEP^® as they continue to fight against high-risk infectious diseases in patients.”

About EXBLIFEP^® (cefepime/enmetazobactam)

EXBLIFEP^® is an intravenous antibiotic fixed-dose combination of enmetazobactam, a novel extended-spectrum β-lactamase inhibitor belonging to the penicillanic acid sulfone class, with the fourth-generation cephalosporin cefepime. Enmetazobactam has been shown to restore the efficacy of cefepime against some multi-drug resistant bacteria, including ESBL-producing pathogens alone or in combination with some resistant β-lactamase mutations as OXA-48 or AmpC, which are increasing in Europe and for which there are few therapeutic alternatives.

EXBLIFEP^® demonstrated statistically significant superior overall treatment success in Allecra’s pivotal Phase III ALLIUM trial, which compared 1034 randomized patients receiving either cefepime 2 g/enmetazobactam 0.5 g or piperacillin 4 g/tazobactam 0.5 g every 8 h as 2 h continuous intravenous infusion in a multi-centre, randomized, controlled, double-blind, global study in 112 sites within nineteen countries.

In February 2024, the U.S. Food and Drug Administration (FDA) approved EXBLIFEP^® as a treatment for complicated urinary tract infections (cUTI), including pyelonephritis, in patients 18 years and older. In March 2024 the European Commission (EC) granted marketing authorisation for EXBLIFEP^® for the treatment of adult patients with cUTI, including pyelonephritis; hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP); and bacteraemia that occurs in association with, or is suspected to be associated with any of the infections listed previously.

About Allecra Therapeutics

Allecra Therapeutics, founded in 2013, is a private, clinical-stage biopharmaceutical company developing novel therapies to combat antibiotic resistance by overcoming emergent resistance mechanisms. Lead product candidate EXBLIFEP^® (cefepime/enmetazobactam), has successfully completed a randomized, controlled, double-blind, global Phase 3 trial compared to standard of care in patients with complicated urinary tract infections (cUTIs). Based on these results, the company has received FDA marketing approval in the U.S. and announced approval in the European Union for EXBLIFEP^® earlier this year.

Allecra has significant patent protection covering proprietary enmetazobactam in major territories. Allecra’s investors include Forbion, Andera Partners, Delos Capital, Xeraya Capital, EMBL Ventures, and BioMedPartners. Allecra’s wholly owned French subsidiary is a beneficiary of financial support from Bpifrance and the Région Alsace. Please visit www.allecra.com for further information.

About Acino

Acino is a Swiss pharmaceutical company headquartered in Zurich with a clear focus on selected markets in the Middle East, Africa, Ukraine, the CIS Region, and Latin America. We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing. For more information, please visit www.acino.swiss.

Acino is part of Arcera, a global company in the life sciences sector headquartered in Abu Dhabi, United Arab Emirates. Arcera was established by ADQ, an Abu Dhabi-based investment and holding company, to build a global life sciences powerhouse poised to make significant contributions to realising the UAE’s aspiration to emerge as a frontrunner in science and technology. To learn more about Arcera, please visit www.arceralifesciences.com.

Attachments

• Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
• Acino and Allecra Therapeutics

For Allecra Therapeutics:
Andreas Kranzusch, Chief Financial Officer and Managing Director
[email protected]

Gretchen Schweitzer, Trophic Communications, +49 172 8618540
[email protected]

For Acino: 
Larisa Bernstein, Global Head of Communications
[email protected]

GlobeNewswire Distribution ID 9157528

SHENZHEN, China and MUNICH, June 21, 2024 (GLOBE NEWSWIRE) — BYD Co. Ltd. (HKSE: 1211), one of the world’s largest rechargeable batteries and electrical vehicles manufacturers, showcased its renewable energy solutions at “The Smarter E Europe” from June 19 to 21. The exhibition at booth B1.130, B1.131 featured the latest BatteryBox energy storage systems, BatteryMax Lite, and BYD MC Cube-T for utility-scale, commercial and industrial applications. Visitors could explore the BYD electrical vehicle “Seal” and learn about BYD’s role as the official E-Mobility Partner for UEFA Euro 2024.

Since its debut in 2015, the BYD BatteryBox series has become a leading residential energy storage solution worldwide, now boasting over 1 million installations with an impeccable safety record. On June 19th at 3:00 pm, BYD hosted a special event to thank its partners. Yin Xiaoqiang, General Manager of BYD Energy Storage presented the certificates and prizes such as UEFA Euro 2024 final tickets and BatteryBox systems to the distributors and installers. The full BYD BatteryBox Premium portfolio, including high-voltage models HVS/HVM and low-voltage models LVL/LVS, were on display. A new battery control unit (BCU) for HVM and HVS series was also introduced, simplifying installation by eliminating the need to remove covers for cable connections.

Launched at ees Europe 2024, the new BatteryMax Lite is designed for commercial and industrial applications, offering scalable solutions from 30kWh to 90kWh, and up to 5.76MWh with parallel connections. Compatible with inverters from brands like SMA and Goodwe, BatteryMax Lite will be available for pre-order from August with shipments starting in late summer, and system availability in Europe expected by October 2024.

On ees Europe 2024, BYD was awarded the recognition of “Top Brand PV Storage Europe 2024” and the “Top Brand PV Storage 2024” country-level awards for several European markets, including Belgium, Germany, Italy, Poland, Spain, Austria, and UK. The award this year again rated BYD as the leading brand for PV energy storage systems based on the evaluations from installers and distributors across Europe.

Jiang Feng, Residential Energy Storage Director at BYD, highlighted the importance of European markets and the company’s goal to provide green energy solutions. BYD’s partnership with UEFA Euro 2024 aligns with promoting eco-friendly energy and mobility solutions.

For more information, visit:

www.byd.com

www.bydenergy.com

www.batterybox.com

Contact information: [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/66a5ccab-1c68-42cb-bbeb-b8fc0862b882

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ada7c6ac-1527-420a-ad1e-c8bf290074c0

GlobeNewswire Distribution ID 9157399

CallTower Welcomes New EMEA Sales Directors and Sales Operations Manager: Pedro Dias, Sean Blackmore, Rick Sellers and Giggsy Jayaweera

SALT LAKE CITY, UT, ROCHESTER, NY, BOSTON, MA, LONDON, June 20, 2024 (GLOBE NEWSWIRE) — CallTower, a global leader in delivering unified communications, contact center, and collaboration solutions, including Microsoft Teams, Webex by Cisco, and Zoom, is thrilled to announce the appointment of Pedro Dias, Sean Blackmore, and Rick Sellers as Sales Directors for the Europe, Middle East, and Africa (EMEA) region and Giggsy Jayaweera as Sales Operations Manager EMEA, reporting to Paul Holden, Vice President of EMEA Sales.

Pedro Dias, with over 18 years of experience, joins CallTower in Portugal, bringing expertise from key positions at BroadSoft, Cisco, and Akixi. His strategic initiatives and client relationships align seamlessly with CallTower’s values, driving growth and partnerships in EMEA, leading Cisco-based initiatives.

Sean Blackmore, an experienced professional in channel partnerships and technology, will lead CallTower’s Microsoft practice and complementary partnerships, including Solgari. His appointment reflects CallTower’s commitment to growth and innovation in Europe.

Rick Sellers joins CallTower EMEA to head the ZOOM team. With a background in technical and sales roles, Rick’s passion for understanding customer needs and experience with various industries make him a valuable addition to the team. Rick’s diverse experience, spanning from the US to Asia, brings a wealth of knowledge to CallTower.

Finally, Giggsy Jayaweera joins the CallTower EMEA Team in the role of Sales Operations Manager EMEA.  Giggsy brings vast experience in operational efficiency and productivity, helping improve selling time. He will work closely with the EMEA Sales Team whilst also working with the existing domestic Sales Operations as CallTower scales globally.

“We are thrilled to welcome Pedro, Sean, Rick and Giggsy to our EMEA team,” said Paul Holden, Vice President of EMEA Sales at CallTower. “Their extensive experience and proven track records will be invaluable as we continue to drive growth and innovation in the region. Having worked with all four new hires in previous roles at different companies, I chose them specifically as both the best in the industry and a great cultural fit for CallTower.”

“As we expand our presence in the EMEA region, I am thrilled to introduce our dynamic new sales team and sales ops members,” confirmed CallTower CRO William Rubio. “Their passion, expertise, and dedication will drive our success and strengthen our commitment to excellence in serving our customers across EMEA.”

CallTower’s expansion into EMEA in recent months has been fast-paced, with announcements regarding the expanded scope of Microsoft Teams Operator Connect into 17 new EMEA territories and the addition of Paul Holden as the Vice President of EMEA Sales in March of 2024.

About CallTower

Transforming how we connect across the globe! Dive into the future of global communication with CallTower, where the forefront of innovation meets the vast expanse of connectivity. CallTower is revolutionizing communications through cutting-edge technology.  CallTower delivers seamless MS Teams, Zoom, and Webex voice solutions elevated by the integration of AI technology, comprehensive contact center solutions and one-click failover, marking a significant milestone in the communication landscape.

Since its establishment in 2002, CallTower has evolved into a global cloud-based, enterprise-class cloud communications (unified communications, contact center and collaboration) solutions provider, catering to the needs of expanding businesses globally. CallTower offers and supports cutting-edge solutions such as Operator Connect for Microsoft® Teams, MS Teams Direct Routing, GCC High Teams Direct Routing, Microsoft® 365, Cisco® Webex Calling / UCM, Cisco® CCP, Zoom Phone, Zoom (BYOB), and a range of contact center options, including Five9 for business customers.

For more information about CallTower and its award-winning services, please contact [email protected]. 

Kade Herbert
CallTower, Inc.
8003475444
[email protected]

GlobeNewswire Distribution ID 9156366

TEMECULA, Calif., June 19, 2024 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group, part of Nikkiso Co. Ltd.’s Industrial division, announced that after its most recent award by SK Plug Hyverse, the Group has contracts to build and maintain approximately two dozen liquid-based hydrogen (LH2) fueling stations in South Korea.

As more buses and heavy-duty trucks look to lower carbon emissions while keeping long-distance driving capabilities, many fleet operators, transit authorities, and agencies are looking to liquid hydrogen as a solution for quick-fills and long-distance routes. Nikkiso’s experience developing and manufacturing cryogenic pumps for more than 70 years and alternative fuels fueling stations for 26 years is attracting companies like SK Plug Hyverse that want capable partners to help grow South Korea’s hydrogen infrastructure and economy.

“SK Plug Hyverse is a tremendous partner for Nikkiso in South Korea because together we bring exceptional capabilities and people to support South Korea’s progressive approach to establishing a competitive hydrogen economy,” said Peter Wagner, CEO, Nikkiso Clean Energy & Industrial Gases. “Nikkiso admires South Korea’s productive and pragmatic approach to scaling up the hydrogen economy, and we look forward to further opportunities supporting its efforts.”

“There aren’t many companies that have Nikkiso’s vertically integrated fueling station with in-house liquification systems and trailer loading systems, cryogenic pumps, vacuum insulated pipe, vacuum insulated vessels, cryogenic vaporizer, industrial controls, permitting, installation, and maintenance services,” said Mike Mackey, President, Fueling & Solutions, Nikkiso Clean Energy & Industrial Gases. “We’ve been building alternative fueling stations since 1998 and are proud that the work we do supports a cleaner, healthier world.”

Several liquid hydrogen stations in South Korea have already been commissioned, successfully fueling buses back-to-back, and ramping up to capacity. The remaining stations in South Korea will be brought online over the next 12 months.

About Nikkiso Clean Energy & Industrial Gases Group

The Nikkiso Clean Energy & Industrial Gases Group is a leading provider of cryogenic equipment, technologies and applications for clean energy and industrial gas market segments. The Group employs more than 1,600 people in 22 countries and is headed by Cryogenic Industries, Inc. in Southern California, U.S., which is a wholly owned subsidiary of Nikkiso Co., Ltd. (TSE: 6376).

Media contact
Lisa Adams
[email protected]
Mobile: +1 (405) 492-1689

About Nikkiso Co. Ltd.

Since its establishment in 1953, Nikkiso has contributed to solving social issues by anticipating the changing times with world-first and Japan-first technologies and products. In the industrial business, Nikkiso has created new markets by developing products in the energy field, hemodialysis-related products in the medical business, and CFRP (carbon fiber reinforced plastic) aerostructures in the aerospace business.

About SK Plug Hyverse

SKPH is a joint venture between SK E&S and Plug Power Inc, a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, to pursue integrated solution businesses throughout the clean hydrogen value chain in Asia.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d45a57fe-03f5-4e5a-a789-57e6efd5cd26

GlobeNewswire Distribution ID 9156294